Key facts
- Notable investors include United States Department of War, National Institutes of Health, Portland Seed Fund, Oregon Nanoscience and Microtechnologies Institute, Oregon Entrepreneurs Network — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Neurosom
- ·The full record, as it builds
Funding rounds
No funding rounds for Neurosom are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Neurosom
Manufacturer of neurotechnology-based sleep therapy devices designed for personalized sleep improvement purposes. The company offers a system that uses a real-time EEG sleep-staging algorithm to deliver gentle, precisely timed electrical stimulation, enabling individuals to initiate sleep more easily and experience deeper, more restorative rest.
- Sector
- Healthcare
- HQ
- Eugene, OR, United States
- Founded
- 2020
- Employees
- 10
- Website
- neurosom.net/
- Ownership
- Privately Held (backing)
Neurosom doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Neurosom shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Neurosom in its N-PORT filings yet. We sweep new filings monthly.